Form D · Pharmaceuticals
STERRX, LLC
Plattsburgh, NY · CIK 0001670452
Offering snapshot reported Sep 21, 2017 · SEC filing
- Reported sold
- $15M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $15M Reported outside-investor minimum
- First sale
- Sep 8, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 21, 2017 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Mar 30, 2016 | Initial | $3,000,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-295166
Source: Form D, filed Sep 21, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vera Delorme | Executive |
| Tana Hanley | Director |
| Gary L Hanley | Director, Executive |
| Sandra Hawkins | Director |
| Jeff La Bombard | Director |
| Carl Martin | Director |
| James, Iii Mc Kee | Executive |
| Kent Smeltz | Director |
| Terry Wiley | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
141 Idaho Ave
Plattsburgh, NY, 12903
Plattsburgh, NY, 12903